Literature DB >> 15777231

Pharmacological and surgical therapy for primary postpartum hemorrhage.

F W Bouwmeester1, A C Bolte, H P van Geijn.   

Abstract

Early postpartum hemorrhage remains a significant cause of maternal morbidity and mortality. Postpartum hemorrhage is most commonly due to uterine atony and often responds to medical treatments such as administration of uterotonic drugs, alone or in combination with uterine massage or bimanual compression. As the incidence of cesarean section continues to rise, the problem of placenta previa and accreta is likely to become more common. For first-line management of postpartum hemorrhage adequate blood and fluid replacement is mandatory. In recent years new therapeutic measures to control the bleeding have gained attention. Although, these newer therapies focus on avoiding the need for emergency hysterectomy and preservation of reproductive function, reports of subsequent pregnancies are still scarce. Established management options are shortly reviewed and novel medical and surgical treatments are more extensively discussed.

Entities:  

Mesh:

Year:  2005        PMID: 15777231     DOI: 10.2174/1381612053381882

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  4 in total

1.  Emergencies associated with pregnancy and delivery: peripartum hemorrhage.

Authors:  Franz Kainer; Uwe Hasbargen
Journal:  Dtsch Arztebl Int       Date:  2008-09-12       Impact factor: 5.594

2.  Uterine artery embolization for primary postpartum hemorrhage.

Authors:  Tae-Hee Kim; Hae-Hyeog Lee; Jun-Mo Kim; Ae-Li Ryu; Soo-Ho Chung; Woo Seok Lee
Journal:  Iran J Reprod Med       Date:  2013-06

3.  Acute Sheehan's syndrome manifesting initially with diabetes insipidus postpartum: a case report and systematic literature review.

Authors:  Gregor Leonhard Olmes; Erich-Franz Solomayer; Julia Caroline Radosa; Panagiotis Sklavounos; Philipp Agne; Stefan J Schunk; Bashar Haj Hamoud
Journal:  Arch Gynecol Obstet       Date:  2021-11-15       Impact factor: 2.493

Review 4.  Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis.

Authors:  Ingrid Pabinger; Dietmar Fries; Herbert Schöchl; Werner Streif; Wolfgang Toller
Journal:  Wien Klin Wochenschr       Date:  2017-04-21       Impact factor: 1.704

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.